ARS Pharmaceuticals Inc
NASDAQ:SPRY
Income Statement
Earnings Waterfall
ARS Pharmaceuticals Inc
Revenue
|
30k
USD
|
Operating Expenses
|
-67.6m
USD
|
Operating Income
|
-67.5m
USD
|
Other Expenses
|
13.2m
USD
|
Net Income
|
-54.4m
USD
|
Income Statement
ARS Pharmaceuticals Inc
Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
1
+2%
|
1
+1%
|
1
N/A
|
0
-98%
|
|
Operating Income | |||||||||||||
Operating Expenses |
(32)
|
(57)
|
(79)
|
(90)
|
(95)
|
(89)
|
(85)
|
(37)
|
(31)
|
(32)
|
(31)
|
(68)
|
|
Selling, General & Administrative |
(11)
|
(18)
|
(25)
|
(28)
|
(29)
|
(30)
|
(33)
|
(18)
|
(27)
|
(33)
|
(37)
|
(47)
|
|
Research & Development |
(21)
|
(39)
|
(54)
|
(62)
|
(66)
|
(59)
|
(52)
|
(18)
|
(20)
|
(16)
|
(11)
|
(20)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
17
|
17
|
0
|
|
Operating Income |
(32)
N/A
|
(57)
-77%
|
(79)
-40%
|
(90)
-13%
|
(95)
-6%
|
(89)
+6%
|
(85)
+5%
|
(36)
+58%
|
(30)
+17%
|
(30)
-3%
|
(29)
+3%
|
(68)
-130%
|
|
Pre-Tax Income | |||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
(1)
|
0
|
0
|
0
|
0
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
(0)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
8
|
11
|
13
|
|
Pre-Tax Income |
(32)
N/A
|
(56)
-77%
|
(79)
-40%
|
(89)
-13%
|
(95)
-6%
|
(90)
+5%
|
(85)
+5%
|
(35)
+59%
|
(25)
+28%
|
(23)
+8%
|
(20)
+13%
|
(54)
-172%
|
|
Net Income | |||||||||||||
Income from Continuing Operations |
(32)
|
(56)
|
(79)
|
(89)
|
(95)
|
(90)
|
(85)
|
(35)
|
(25)
|
(23)
|
(20)
|
(54)
|
|
Net Income (Common) |
(32)
N/A
|
(56)
-77%
|
(79)
-40%
|
(89)
-13%
|
(95)
-6%
|
(90)
+5%
|
(85)
+5%
|
(35)
+59%
|
(25)
+28%
|
(23)
+8%
|
(20)
+13%
|
(54)
-172%
|
|
EPS (Diluted) |
-0.91
N/A
|
-1.61
-77%
|
-2.26
-40%
|
-2.56
-13%
|
-2.72
-6%
|
-2.57
+6%
|
-2.42
+6%
|
-0.87
+64%
|
-0.26
+70%
|
-0.24
+8%
|
-0.2
+17%
|
-0.57
-185%
|